Skip to main content

Table 2 Clinical character and impact of migraine (Number = 60)

From: Risk factors of white matter hyperintensities in migraine patients

Variables

Migraine Cohort

Mean + SD/Number (%) N = 60

Diagnosis

 • Episodic Migraine

• 52 (86.7)

 • Chronic Migraine

• 8 (13.3)

 • Migraine with aura

• 12 (20)

 • Migraine without aura

• 48 (80)

Mean disease duration in years

10.97+  7.56

Range

1–29

Mean Frequency of migraine headache/ month

5.65+  6.36

1–30

Mean duration of migraine headache in hours

14.19+  12.02

Range

2–72

Mean number of analgesic days

12.11 ± 6.69.

Use of prophylactic treatment

29 (48.3)

VAS

8.30+ 1.67

Range

2–10

Mean HIT 6 score

64.12 +  10.29

Range

39–78

Mean MIDAS score

51.42 +  57.70

Range

0–240

  1. HIT-6 Headache Impact Test, MIDAS Migraine Disability Assessment Scale, MoCA Montreal Cognitive Assessment, NA not available, NC normal control, SD standard deviation, VAS visual analogue scale, WMHs White matter hyperintensities
  2. *A significance level, P < 0.05